Please provide your email address to receive an email when new articles are posted on . The American Society of Nephrology has announced the second year of its loan mitigation program, which provides ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today provided ...

(MENAFN- GlobeNewsWire - Nasdaq) SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small ...

A transitional dialysis program piloted in Austin, TX lowered the use ofcostly emergency dialysis in uninsured people with kidney failure, and it facilitated permanent dialysis access placement and ...